Levodopa-induced dyskinesia in parkinson’s disease: pathogenesis and emerging treatment strategies

HIGHLIGHTS

  • who: Destany K. Kwon and colleagues from the The Johns Hopkins University School of Medicine, Baltimore, MD, USA have published the research: Levodopa-Induced Dyskinesia in Parkinsonu2019s Disease: Pathogenesis and Emerging Treatment Strategies, in the Journal: Cells 2022, 3736 of 23/Nov/2022
  • what: The overall goal of the study is to look for the possible (PDQ-39), the Parkinson`s Disease Quality of Life Scale (PDQUALIF), and the Home Diary. anticipated mechanisms involved in LID and the currently available therapeutics that are

SUMMARY

    As PD progresses, the common motor symptoms . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?